Henry Meds, MD-Led Platform

Henry Meds is a telehealth platform founded to make GLP-1 weight loss medications accessible and affordable for patients who cannot or do not want to go through traditional insurance channels. The company specializes in compounded semaglutide and tirzepatide — medications formulated by FDA-registered compounding pharmacies and dispensed without the brand-name price tag of Wegovy or Mounjaro. The clinical model is deliberately lean. Henry Meds offers both synchronous (video) and asynchronous provider consultations depending on the patient''s state, with ongoing care managed primarily through monthly refill surveys reviewed by a licensed provider. There is no health coaching program, no dietitian support, and no behavioral curriculum — Henry Meds is a prescription and medication delivery service, not a comprehensive weight management program. This is a feature for many patients and a limitation for others. Pricing is tiered by plan length and format. Injectable compounded semaglutide starts at $147/month, with oral tablets available at $99/month. Longer-plan commitments (three, six, or twelve months prepaid) reduce the per-month cost substantially. Pricing scales with dosage increases, which patients should factor into their long-term budget. Henry Meds does not accept health insurance; all costs are cash-pay, though HSA and FSA cards are accepted. The platform currently serves patients in 41 states, with Alabama, Alaska, Arkansas, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, and West Virginia excluded due to state regulations around compounded medication prescribing. This is an important caveat for prospective patients to verify before beginning the signup process. Henry Meds competes in a crowded market for low-cost compounded GLP-1 access alongside services like Hims, Hers, Ro, and Mochi Health. Its competitive advantage is transparent, tiered pricing and a clinical workflow that feels more medically grounded than some consumer-facing alternatives. For patients who have done their research on GLP-1 medications and want affordable access without the overhead of a comprehensive program, Henry Meds is a straightforward option worth evaluating. The company specializes in compounded semaglutide and tirzepatide — medications formulated by FDA-registered compounding pharmacies and dispensed without the brand-name price tag of Wegovy or Mounjaro. The clinical model is deliberately lean. Henry Meds offers both synchronous (video) and asynchronous provider consultations depending on the patient''s state, with ongoing care managed primarily through monthly refill surveys reviewed by a licensed provider. There is no health coaching program, no dietitian support, and no behavioral curriculum — Henry Meds is a prescription and medication delivery service, not a comprehensive weight management program. This is a feature for many patients and a limitation for others. Pricing is tiered by plan length and format. Injectable compounded semaglutide starts at $147/month, with oral tablets available at $99/month. Longer-plan commitments (three, six, or twelve months prepaid) reduce the per-month cost substantially. Pricing scales with dosage increases, which patients should factor into their long-term budget. Henry Meds does not accept health insurance; all costs are cash-pay, though HSA and FSA cards are accepted. The platform currently serves patients in 41 states, with Alabama, Alaska, Arkansas, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, and West Virginia excluded due to state regulations around compounded medication prescribing. This is an important caveat for prospective patients to verify before beginning the signup process. Henry Meds competes in a crowded market for low-cost compounded GLP-1 access alongside services like Hims, Hers, Ro, and Mochi Health. Its competitive advantage is transparent, tiered pricing and a clinical workflow that feels more medically grounded than some consumer-facing alternatives. For patients who have done their research on GLP-1 medications and want affordable access without the overhead of a comprehensive program, Henry Meds is a straightforward option worth evaluating.